Despite the remarkable success of molecular targeted therapy in recent years, the rapid increase of drug resistance is a major obstacle to effective treatment of lung cancer.
How do lung cancer cells adapt to targeted therapy? What is the molecular basis of such adaptive behavior? Can this adaptive response be memorized by cancer cells? If so, is it heritable? The answers to these questions will provide a deeper understanding of the evolutionary process of drug resistance during molecular targeted therapy.
In a study published in Cell Reports, research teams revealed the important role of epigenetic regulation-mediated metabolic reprogramming in lung cancer's capacity to resist molecular targeted therapy.
The researchers found that low-dose targeted drug pretreatment allowed epidermal growth factor receptor (EGFR)-mutant lung cancer cells to adapt to subsequent high-dose drug treatment, thus exhibiting a transient drug-tolerant state. They also found that continuous stimulation with low-dose drugs reinforced this adaptive response, and eventually promoted the development of drug resistance.
Such adaptive behavior occurs not only in EGFR-mutant lung cancer, but also in ALK-rearranged lung cancer, thus indicating this phenomenon is not restricted to one lung cancer type.
In addition, the researchers revealed the molecular basis of this adaptive response, which involves epigenetic regulation-mediated metabolic reprogramming. During the adaptation of lung cancer cells to drug therapy, the level of intracellular histone H3K9 methylation is reduced, thus up-regulating the branched-chain amino acid aminotransferase 1 (BCAT1). In this process, more glutathione is generated by BCAT1, thereby effectively eliminating detrimental oxidative stress caused by targeted therapy and eventually causing drug resistance.
Not surprisingly, correlation analyses of clinical data showed that high expression of BCAT1 in tumors is associated with an unfavorable therapeutic response to drug treatment and predicts poor patient prognosis.
However, using preclinical mouse models, the researchers demonstrated that the combination of targeted therapies with reactive oxygen species (ROS)-inducing drugs can effectively overcome lung cancer drug resistance, suggesting a potential therapeutic strategy for dealing with such drug resistance.
http://english.cas.cn/newsroom/research_news/201907/t20190708_212718.shtml
https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30792-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fbranched-chain-amino_2&filter=22
Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer
- 2,058 views
- Added
Edited
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Polygenic risk score may be a better tool to assess the breast canc…
Read more
How Immune Cells Support Breast Cancer Progression
Read more
Inhibiting mtDNA transcription to stop cancer growth
Read more
Fat1 deletion promotes hybrid EMT state, tumor stemness and metastasis
Read more
AI-powered microscope could check cancer margins in minutes
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar